LACTOPRES:Study on the Effect of Dairy Peptides on Blood Pressure in Untreated Hypertensive Subjects.

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00167869

Enrollment

135

Registered

2005-09-14

Start date

2004-06-30

Completion date

2005-06-30

Last updated

2008-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

hypertension, blood pressure, dairy peptides, bioactive peptides, randomized controlled trial

Brief summary

Hypertension is an increasingly important medical and public health issue. Literature suggests that there may be a role for dairy foods in the prevention and treatment of hypertension. Recently, it has been suggested that several peptides in milk proteins could have blood pressure lowering properties. LACTOPRES is a randomised, double-blind parallel trial to assess the blood pressure effect of an increased intake of dairy peptides in humans.

Interventions

BEHAVIORALdairy peptides

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

DOUBLE

Eligibility

Sex/Gender

ALL

Age

35 Years to 70 Years

Healthy volunteers

Yes

Inclusion criteria

* systolic blood pressure \>= 140 mmHg * BMI between 18 and 32 kg/m2 * apparently healthy

Exclusion criteria

* antihypertensive medication * medically prescribed or slimming diet * lactating, pregnant * irregular pulse

Design outcomes

Primary

Measure	Time frame
Blood pressure	—

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026